Merge, Omnicare pair for global trials
Omnicare Clinical Research will implement Merge CIMS as a part of its end-to-end system for image management of oncology, cardiology and ophthalmology clinical trials.
Omnicare will use Merge CIMS paired with Merge EDC to conduct an upcoming global colorectal cancer trial slated to collect and review 2,750 exams from 550 patients at 40 sites over five years.
Along with Merge CIMS, Omnicare plans to leverage AG Mednet’s image transfer technology and radiology expertise from Intrinsic Imaging to build a complete virtual imaging core lab solution. The Merge CIMS role is to automate the full workflow of image submission, image storage in a vendor-neutral DICOM archive and image review and analysis.
Chicago-based Merge develops healthcare data and diagnostic workflow systems. Headquartered in King of Prussia, Penn., Omnicare is a contract research organization serving the biopharmaceutical and medical device industries.
Omnicare will use Merge CIMS paired with Merge EDC to conduct an upcoming global colorectal cancer trial slated to collect and review 2,750 exams from 550 patients at 40 sites over five years.
Along with Merge CIMS, Omnicare plans to leverage AG Mednet’s image transfer technology and radiology expertise from Intrinsic Imaging to build a complete virtual imaging core lab solution. The Merge CIMS role is to automate the full workflow of image submission, image storage in a vendor-neutral DICOM archive and image review and analysis.
Chicago-based Merge develops healthcare data and diagnostic workflow systems. Headquartered in King of Prussia, Penn., Omnicare is a contract research organization serving the biopharmaceutical and medical device industries.